Literature DB >> 15049509

Tetrapeptides on N- and C-terminal regions of mastoparan inhibit catecholamine release from chromaffin cells by blocking nicotinic acetylcholine receptor.

Noriyuki Monoi1, Masaya Usui, Shunichi Takahashi, Hisashi Ito, Konosuke Kumakura, Hisataka Kasai.   

Abstract

Mastoparan (MP), a tetradecapeptide in wasp venom, has been reported to evoke catecholamine release, but also reported to inhibit secretory response upon nicotinic stimulation in adrenal chromaffin cells. To elucidate the inhibitory mechanism of MP, we examined the effect of two MP fragments (INLK-NH2 and KKIL-NH2) on catecholamine release in bovine adrenal chromaffin cells. These MP fragments inhibited catecholamine release induced by nicotinic stimulation in a noncompetitive manner. These fragments did not affect catecholamine release evoked by high [K+] or by other secretagogues, neither caused catecholamine release by themselves. Replacement by hydrophobic and basic amino acids of the MP fragments enhanced the inhibitory effects on ACh-evoked catecholamine release. Among 23 analogs of the MP fragments, (Nle)3-R-NH2 showed the most potent inhibition with IC50 = 541 microM. These results suggested that the MP fragments selectively inhibit the secretory response to nicotinic stimulation by attacking nAChR on the site(s) made up of hydrophobic and acidic amino acids but other than ACh-binding sites. This mechanism may explain the inhibitory action of MP on nicotine-evoked catecholamine release.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15049509     DOI: 10.1023/b:cemn.0000012723.52742.84

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  20 in total

1.  Catestatin (chromogranin A344-358) stimulates release of histamine from rat pleural and peritoneal mast cells.

Authors:  P-G Krüuger; S K Mahata; K B Helle
Journal:  Ann N Y Acad Sci       Date:  2002-10       Impact factor: 5.691

Review 2.  G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides.

Authors:  M Mousli; J L Bueb; C Bronner; B Rouot; Y Landry
Journal:  Trends Pharmacol Sci       Date:  1990-09       Impact factor: 14.819

Review 3.  The functional architecture of the acetylcholine nicotinic receptor explored by affinity labelling and site-directed mutagenesis.

Authors:  J P Changeux; J L Galzi; A Devillers-Thiéry; D Bertrand
Journal:  Q Rev Biophys       Date:  1992-11       Impact factor: 5.318

4.  Effects of mastoparan on catecholamine release from chromaffin cells.

Authors:  S P Wilson
Journal:  FEBS Lett       Date:  1989-04-24       Impact factor: 4.124

5.  Characterization of bradykinin-stimulated release of noradrenaline from cultured bovine adrenal chromaffin cells.

Authors:  P J Owen; R Plevin; M R Boarder
Journal:  J Pharmacol Exp Ther       Date:  1989-03       Impact factor: 4.030

6.  Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins).

Authors:  T Higashijima; S Uzu; T Nakajima; E M Ross
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

7.  Acetylcholine receptor channel imaged in the open state.

Authors:  N Unwin
Journal:  Nature       Date:  1995-01-05       Impact factor: 49.962

8.  Activation of rat peritoneal mast cells by substance P and mastoparan.

Authors:  M Mousli; C Bronner; J L Bueb; E Tschirhart; J P Gies; Y Landry
Journal:  J Pharmacol Exp Ther       Date:  1989-07       Impact factor: 4.030

9.  Modulatory mechanism of the endogenous peptide catestatin on neuronal nicotinic acetylcholine receptors and exocytosis.

Authors:  Carlos J Herrero; Eva Alés; Antonio J Pintado; Manuela G López; Esther García-Palomero; Sushil K Mahata; Daniel T O'Connor; Antonio G García; Carmen Montiel
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

10.  Essential role of myosin light chain kinase in the mechanism for MgATP-dependent priming of exocytosis in adrenal chromaffin cells.

Authors:  K Kumakura; K Sasaki; T Sakurai; M Ohara-Imaizumi; H Misonou; S Nakamura; Y Matsuda; Y Nonomura
Journal:  J Neurosci       Date:  1994-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.